Chen Lyu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Epigenetics and DNA Methylation 5
- RNA modifications and cancer 3
- Congenital heart defects research 3
- Oncology 5
- Cancer Cells and Metastasis 2
- Co-authors
- Heike Pohla (7 shared papers)Alexander Büchner (7 shared papers)Lili Wang (3 shared papers)Jinkyung Ha (1 shared paper)Christine T. Cigolle (1 shared paper)Mohammed U. Kabeto (1 shared paper)Caroline Blaum (1 shared paper)Ying Gao (2 shared papers)
- Journals
- IEEE Transactions on Mobile Computing (1 paper)JAMA Network Open (1 paper)The Prostate (1 paper)Photodiagnosis and Photodynamic Therapy (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Chen Lyu
28 papers receiving 198 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 39
- Toxicology 8
- Applied Microbiology and Biotechnology 3
- Oncology 37
- Molecular Biology 91
Countries citing papers authored by Chen Lyu
This map shows the geographic impact of Chen Lyu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Lyu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Lyu more than expected).
Fields of papers citing papers by Chen Lyu
This network shows the impact of papers produced by Chen Lyu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Lyu. The network helps show where Chen Lyu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen Lyu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 32 | |
| 2 | 2019 | 30 | |
| 3 | Shikonin enhances the antitumor effect of cabazitaxel in prostate cancer stem cells and reverses cabazitaxel resistance by inhibiting ABCG2 and ALDH3A1. | 2020 | 23 |
| 4 | 2022 | 15 | |
| 5 | 2022 | 10 | |
| 6 | 2024 | 9 | |
| 7 | 2023 | 9 | |
| 8 | 2021 | 9 | |
| 9 | 2022 | 7 | |
| 10 | 2021 | 6 | |
| 11 | 2021 | 5 | |
| 12 | 2023 | 5 | |
| 13 | 2019 | 5 | |
| 14 | 2024 | 4 | |
| 15 | 2025 | 4 | |
| 16 | 2015 | 4 | |
| 17 | 2024 | 3 | |
| 18 | 2021 | 3 | |
| 19 | 2021 | 3 | |
| 20 | 2021 | 3 |
About Chen Lyu
Chen Lyu is a scholar working on Molecular Biology, Oncology, Epidemiology, Cancer Research and Pediatrics, Perinatology and Child Health, having authored 29 papers that have together received 200 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), RNA modifications and cancer (3 papers), Congenital heart defects research (3 papers), MicroRNA in disease regulation (3 papers), Cancer Cells and Metastasis (2 papers), Bioactive Compounds and Antitumor Agents (2 papers), Congenital Heart Disease Studies (2 papers) and Magneto-Optical Properties and Applications (1 paper). The work is most often cited by research in Cancer Research (39 citations), Toxicology (8 citations), Applied Microbiology and Biotechnology (3 citations), Oncology (37 citations) and Molecular Biology (91 citations). Chen Lyu has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Heike Pohla, Alexander Büchner, Lili Wang, Jinkyung Ha, Christine T. Cigolle, Mohammed U. Kabeto, Caroline Blaum, Ying Gao, Lili Wang and Yan Zhang. Their work appears in journals such as IEEE Transactions on Mobile Computing, JAMA Network Open, The Prostate, Photodiagnosis and Photodynamic Therapy and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.